BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35278097)

  • 1. An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs.
    Couvelard A; Cros J
    Virchows Arch; 2022 Jun; 480(6):1129-1148. PubMed ID: 35278097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in histopathological classification and tissue biomarkers of digestive neuroendocrine neoplasms: What the clinician should know.
    Couvelard A; Cazes A; Cros J
    Best Pract Res Clin Endocrinol Metab; 2023 Sep; 37(5):101795. PubMed ID: 37429760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
    Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between WHO Classification and Location- and Functionality-Based Classifications of Neuroendocrine Neoplasms of the Digestive Tract.
    Helderman NC; Suerink M; Kilinç G; van den Berg JG; Nielsen M; Tesselaar MET
    Neuroendocrinology; 2024; 114(2):120-133. PubMed ID: 37690447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
    Anlauf M
    Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Gastroenteropancreatic Neuroendocrine Neoplasms: From Mysteries to Paradigm Shifts.
    Ramírez-Rentería C; Ferreira-Hermosillo A; Marrero-Rodríguez D; Taniguchi-Ponciano K; Melgar-Manzanilla V; Mercado M
    Arch Med Res; 2020 Nov; 51(8):765-776. PubMed ID: 32654882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
    Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications.
    Klöppel G
    Visc Med; 2017 Oct; 33(5):324-330. PubMed ID: 29177160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
    Kim JY; Hong SM
    Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
    Fottner C; Ferrata M; Weber MM
    Rev Endocr Metab Disord; 2017 Dec; 18(4):393-410. PubMed ID: 29256148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates.
    Chai SM; Brown IS; Kumarasinghe MP
    Histopathology; 2018 Jan; 72(1):153-167. PubMed ID: 29239038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates on lung neuroendocrine neoplasm classification.
    Vocino Trucco G; Righi L; Volante M; Papotti M
    Histopathology; 2024 Jan; 84(1):67-85. PubMed ID: 37794655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Approach to Neuroendocrine Neoplasms of the Gastrointestinal Tract and Pancreas.
    Uccella S; Sessa F; La Rosa S
    Turk Patoloji Derg; 2015; 31 Suppl 1():113-27. PubMed ID: 26177322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.
    Uccella S; La Rosa S; Volante M; Papotti M
    Endocr Pathol; 2018 Jun; 29(2):150-168. PubMed ID: 29520563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms.
    La Rosa S
    Endocr Pathol; 2021 Jun; 32(2):245-257. PubMed ID: 33786701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of new classification of gastroenteropancreatic neuroendocrine neoplasms].
    Zhu XZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):12-4. PubMed ID: 23691561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Difficulties and challenges in pathological diagnosis of gastrointestinal pancreatic neuroendocrine tumors].
    Luo J; Shi YF
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):996-999. PubMed ID: 35399018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs).
    Effraimidis G; Knigge U; Rossing M; Oturai P; Rasmussen ÅK; Feldt-Rasmussen U
    Semin Cancer Biol; 2022 Feb; 79():141-162. PubMed ID: 33905872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should incidental NEN of the pancreas and gastrointestinal tract be followed?
    Ariotti R; Partelli S; Muffatti F; Andreasi V; Della Sala F; Falconi M
    Rev Endocr Metab Disord; 2018 Jun; 19(2):139-144. PubMed ID: 29527619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
    Klöppel G
    Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.